Table 1. Cell cycle phases' distribution in NB4 cells treated with fucoidan, ATO or in combination.

		Sub G0/G1	G0/G1	S	Mitosis
ATO 0.25 μM	Control	1.93 ± 0.3	42.46 ± 1.39	22.34 ± 0.06	31.67 ± 1.34
	Fucoidan	18.34 ± 1.75	28.66 ± 1.42	22.38 ± 2.7	29.18 ± 3.38
	ATO	2.73 ± 1.08	45.10 ± 0.54	20.22 ± 0.41	30.39 ± 0.87
	Combination	20.69 ± 1.54	31.30 ± 0.09	25.8 ± 2.68	19.44 ± 2.04
ATO 0.5 μM	Control	1.93 ± 0.3	42.46 ± 1.39	22.34 ± 0.06	31.67 ± 1.34
	Fucoidan	18.34 ± 1.75	28.66 ± 1.42	22.38 ± 2.7	29.18 ± 3.38
	ATO	2.39 ± 1.08	46.10 ± 0.54	20.22 ± 0.41	29.39 ± 0.87
	Combination	25.57 ± 0.86	38.42 ± 1.38	15.20 ± 0.34	18.14 ± 1.66
ATO 1.0 μM	Control	1.93 ± 0.3	42.46 ± 1.39	22.34 ± 0.06	31.67 ± 1.34
	Fucoidan	18.34 ± 1.75	28.66 ± 1.42	22.38 ± 2.7	29.18 ± 3.38
	ATO	15.13 ± 0.4	39.81 ± 3.82	16.56 ± 0.8	25.50 ± 2.11
	Combination	74.51 ± 2.26	7.29 ± 1.36	9.28 ± 2.28	6.76 ± 0.7

NB4 cells were treated with with low and therapeutic doses of ATO with or without fucoidan (20 μg/ml) and cell cycle was analyzed after 48 hours. Data represents Mean±SEM of three replicates.